These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 31426556)

  • 1. The Phylum Bryozoa as a Promising Source of Anticancer Drugs.
    Figuerola B; Avila C
    Mar Drugs; 2019 Aug; 17(8):. PubMed ID: 31426556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery.
    Tian XR; Tang HF; Tian XL; Hu JJ; Huang LL; Gustafson KR
    Future Med Chem; 2018 Jun; 10(12):1497-1514. PubMed ID: 29788787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkaloids from marine invertebrates as important leads for anticancer drugs discovery and development.
    Imperatore C; Aiello A; D'Aniello F; Senese M; Menna M
    Molecules; 2014 Dec; 19(12):20391-423. PubMed ID: 25490431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marine natural products: bryostatins in preclinical and clinical studies.
    Kollár P; Rajchard J; Balounová Z; Pazourek J
    Pharm Biol; 2014 Feb; 52(2):237-42. PubMed ID: 24033119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review.
    Raghuvanshi R; Bharate SB
    Curr Top Med Chem; 2020; 20(12):1124-1135. PubMed ID: 32209043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A concise review on marine bromopyrrole alkaloids as anticancer agents.
    Mahamed S; Motal R; Govender T; Dlamini N; Khuboni K; Hadeb Z; Shaik BB; Moodley K; Balaso Mohite S; Karpoormath R
    Bioorg Med Chem Lett; 2023 Jan; 80():129102. PubMed ID: 36496202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Diversity and Biological Activity of Secondary Metabolites Isolated from Indonesian Marine Invertebrates.
    Izzati F; Warsito MF; Bayu A; Prasetyoputri A; Atikana A; Sukmarini L; Rahmawati SI; Putra MY
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33801617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrobeaniamine A, a new alkaloid from the Arctic marine bryozoan
    Michael P; Hansen E; Isaksson J; Andersen JH; Hansen KØ
    Nat Prod Res; 2020 Jul; 34(14):2059-2064. PubMed ID: 30784299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the Anti-Prostate Cancer Properties of Marine-Derived Compounds.
    Fan M; Nath AK; Tang Y; Choi YJ; Debnath T; Choi EJ; Kim EK
    Mar Drugs; 2018 May; 16(5):. PubMed ID: 29757237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Phylum Bryozoa: From Biology to Biomedical Potential.
    Ciavatta ML; Lefranc F; Vieira LM; Kiss R; Carbone M; van Otterlo WAL; Lopanik NB; Waeschenbach A
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32283669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine natural products.
    Carroll AR; Copp BR; Davis RA; Keyzers RA; Prinsep MR
    Nat Prod Rep; 2021 Mar; 38(2):362-413. PubMed ID: 33570537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs.
    Ruiz-Torres V; Encinar JA; Herranz-López M; Pérez-Sánchez A; Galiano V; Barrajón-Catalán E; Micol V
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28644406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel brominated metabolites from Bryozoa: a functional analysis.
    Maltseva AL; Kotenko ON; Kutyumov VA; Matvienko DA; Shavarda AL; Winson MK; Ostrovsky AN
    Nat Prod Res; 2017 Aug; 31(16):1840-1848. PubMed ID: 27897055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medicinal potential of promising marine macrolides with anticancer activity.
    Qi Y; Ma S
    ChemMedChem; 2011 Mar; 6(3):399-409. PubMed ID: 21302362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marine natural products.
    Blunt JW; Carroll AR; Copp BR; Davis RA; Keyzers RA; Prinsep MR
    Nat Prod Rep; 2018 Jan; 35(1):8-53. PubMed ID: 29335692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Marine Secondary Metabolites Worthy of Development as Anticancer Agents: A Review.
    Mbaoji FN; Nweze JA; Yang L; Huang Y; Huang S; Onwuka AM; Peter IE; Mbaoji CC; Jiang M; Zhang Y; Pan L; Yang D
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule-targeting anticancer agents from marine natural substance.
    Liu Z; Xu P; Wu T; Zeng W
    Anticancer Agents Med Chem; 2014 Mar; 14(3):409-17. PubMed ID: 24533652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
    Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
    Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinase-Inhibitory Nucleoside Derivatives from the Pacific Bryozoan
    Bracegirdle J; Gordon DP; Harvey JE; Keyzers RA
    J Nat Prod; 2020 Feb; 83(2):547-551. PubMed ID: 31961676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry and clinical biology of the bryostatins.
    Mutter R; Wills M
    Bioorg Med Chem; 2000 Aug; 8(8):1841-60. PubMed ID: 11003129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.